1-(2-{[(4-methoxyphenyl)methyl]amino}pyridin-4-yl)ethan-1-one | 916765-80-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(2-{[(4-methoxyphenyl)methyl]amino}pyridin-4-yl)ethan-1-one
• 英文别名: 1-(2-(4-methoxybenzylamino)pyridin-4-yl)ethanone；2-p-methoxybenzylamino-4-acetylpyridine；1-[2-[[(4-Methoxyphenyl)methyl]amino]-4-pyridinyl]ethanone；1-[2-[(4-methoxyphenyl)methylamino]pyridin-4-yl]ethanone
• CAS: 916765-80-5
• 化学式: C₁₅H₁₆N₂O₂
• 分子量: 256.304
• InChiKey: FSHMGGNKWUSEOO-UHFFFAOYSA-N

物化性质

• 沸点：
  441.0±40.0 °C(Predicted)
• 密度：
  1.173±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  51.2
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-(2-{[(4-methoxyphenyl)methyl]amino}pyridin-4-yl)ethan-1-one 在 氢溴酸 、 溴 、 溶剂黄146 作用下， 反应 2.0h， 以0.38 g的产率得到1-(2-aminopyridin-4-yl)-2-bromoethan-1-one dihydrobromide
  参考文献：
  名称：

  [EN] PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS
  [FR] DÉRIVÉS DE PYRIDINONE ET DE PYRIMIDINONE COMME INHIBITEURS DU FACTEUR XIA

  摘要：

  本发明提供了一般式(I)的化合物，它们的盐和N-氧化物，以及它们的溶剂合物和前药（其中字符如描述中所定义）。一般式(I)的化合物是因子XIa的抑制剂，因此它们在预防和/或治疗血栓栓塞疾病方面是有用的。

  公开号：

  WO2013093484A1
• 作为产物：
  描述：

  4-氰基-2-氟吡啶 在 2,4-滴二甲胺盐 作用下， 以 乙醚 为溶剂， 反应 1.0h， 生成 1-(2-{[(4-methoxyphenyl)methyl]amino}pyridin-4-yl)ethan-1-one
  参考文献：
  名称：

  Convenient synthesis of N-(4-(2-aminopyridin-4-yl)thiazol-2-yl)-2-phenylacetamides

  摘要：

  We report a facile one-pot, three-step synthesis of N-(4-(2-aminopyridin-4-yl)thiazol-2-yl)-2-phenylacetamides via condensation of 2-p-methoxybenzylamino-4-acetylpyridine with phenylacetylthioureas. Published by Elsevier Ltd.

  DOI：

  10.1016/j.tetlet.2006.09.053

文献信息

• Selective inhibitors of rock protein kinase and uses thereof
  申请人：Green Jeremy

  公开号：US20070270386A1

  公开（公告）日：2007-11-22

  Described herein are compounds that are useful as ROCK inhibitors. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including cardiovascular, inflammatory, neurological, or proliferative diseases or disorders.

  本文描述了作为ROCK抑制剂有用的化合物。这些化合物及其药学上可接受的组合物对于治疗或减轻各种疾病的严重程度是有用的，包括心血管、炎症、神经系统或增殖性疾病或疾病。
• RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM
  申请人：Mitsubishi Gas Chemical Company, Inc.

  公开号：US20160145231A1

  公开（公告）日：2016-05-26

  A resist composition containing a compound represented by the general formula (1) or (2), a method for forming a resist pattern using the composition, a polyphenolic compound for use in the composition, and an alcoholic compound that can be derived therefrom are described.

  描述了一种包含由通式（1）或（2）表示的化合物的光刻胶组合物，使用该组合物形成光刻胶图案的方法，用于该组合物的多酚化合物，以及可以由其衍生的醇化合物。
• OPTICAL COMPONENT FORMING COMPOSITION AND CURED PRODUCT THEREOF
  申请人：Mitsubishi Gas Chemical Company, Inc.

  公开号：US20200262787A1

  公开（公告）日：2020-08-20

  The present invention provides an optical component forming composition comprising a tellurium-containing compound or a tellurium-containing resin.

  本发明提供了一种包括含碲化合物或含碲树脂的光学元件成型组合物。
• METHOD FOR PRODUCING COMPOUND HAVING ACID-LABILE GROUP
  申请人：Kyowa Hakko Chemical Co., Ltd.

  公开号：EP1661918A1

  公开（公告）日：2006-05-31

  The present invention provides a process for producing a compound having a group represented by general formula (II): (wherein R1, R2, and R3 may be the same or different, and each represent a substituted or unsubstituted alkyl, a substituted or unsubstituted aryl, or a substituted or unsubstituted aralkyl, or R1 and R2 may bind to each other to form an alicyclic hydrocarbon ring together with the adjacent carbon atoms, or R2 and R3 may bind to each other to form a alicyclic heterocyclic ring together with the adjacent O-C-C that may have a substituent), which comprises allowing a compound having a hydroxyl group to react with halogenated alkyl ether represented by general formula (I): (wherein R1, R2, and R3 are the same as those defined above, respectively and X represents a halogen atom).

  本发明提供了一种生产具有由通式（II）表示的基团的化合物的方法：（其中R1、R2和R3可以相同也可以不同，并且分别表示取代或未取代的烷基、取代或未取代的芳基、或取代或未取代的芳基烷基，或者R1和R2可以相互结合形成与相邻碳原子一起的脂环碳氢环，或者R2和R3可以相互结合形成与相邻的O-C-C一起具有取代基的脂环杂环）的方法，该方法包括允许具有羟基的化合物与由通式（I）表示的卤代烷基醚发生反应：（其中R1、R2和R3分别与上述定义相同，X代表卤素原子）。
• PROCESS FOR PRODUCING ETHER COMPOUND
  申请人：Kyowa Yuka Co., Ltd.

  公开号：EP1415968A1

  公开（公告）日：2004-05-06

  The present invention provides the following process for produci ng and the like, which enables the production of an ether compound, which is useful for chemical amplification type resist compositions, synthetic intermediates of pharmaceuticals, paints, or the like, with less side reaction and in high yield. A process for producing an ether compound having a group represented by the general formula (II) wherein R1, R2 and R3 may be the same or different, and represent substituted or unsubstituted alkyl, substituted or unsubstituted aryl or substituted or unsubstituted aralkyl, or R1 and R2 form cycloalkyl together with an adjacent carbon atom,    which comprises allowing a compound having a hydroxyl group (including a carboxyl group) to react with an alkenyl ether represented by the general formula (I) wherein R1, R2 and R3 have the same significances as defined above, respectively.

  本发明提供了以下用于生产等的过程，该过程能够生产醚化合物，该化合物对于化学放大型抗蚀组合物、药物合成中间体、涂料等具有用途，且副反应较少且产率高。一种生产具有由通式（II）表示的基团的醚化合物的方法，其中R1、R2和R3可以相同也可以不同，并表示取代或未取代的烷基、取代或未取代的芳基或取代或未取代的芳基烷基，或者R1和R2与相邻碳原子一起形成环烷基，包括允许具有羟基（包括羧基）的化合物与由通式（I）表示的烯基醚发生反应，其中R1、R2和R3分别具有上述定义的相同含义。